基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 31.72
成立日期: 11/12/2017
 
分析
市值分佈:
74.04%
大市值
3.95%
中市值
1.36%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 314  
0%
 
100%
     10大 (23.97%)
代號 名稱 佔比% ▼ 持有日期
JCIJohnson Controls International plc0.3230/09/2026
ORKAOruka Therapeutics Inc0.3130/10/2026
ALKSAlkermes plc0.2930/10/2026
PTGXProtagonist Therapeutics0.2930/10/2026
GILDGilead Sciences0.2930/09/2026
CRSPCRISPR Therapeutics AG0.2930/09/2026
BBIOBridgeBio Pharma0.2930/10/2026
KRYSKrystal Biotech0.2830/10/2026
GRALGRAIL Inc.0.2830/10/2026
NBIXNeurocrine Biosciences0.2830/10/2026
RVMDRevolution Medicines0.2730/10/2026
BMRNBioMarin Pharmaceutical0.2730/10/2026
CICigna Group (The)0.2630/10/2026
PTCTPTC Therapeutics0.2630/10/2026
ROIVRoivant Sciences Ltd0.2630/10/2026
INSMInsmed Incorporated0.2630/10/2026
KODKodiak Sciences0.2530/10/2026
AMATApplied Materials0.2530/10/2026
CYTKCytokinetics0.2530/10/2026
PRAXPraxis Precision Medicines0.2530/10/2026
  1    2    3   4    5    6    7    8    9    10    11    12    13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.